Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

被引:0
|
作者
Zhang, Xinyue [1 ,2 ]
Yang, Jie [1 ,2 ]
Xiang, Yang [1 ]
Wu, Ming [1 ]
Cao, Dongyan [1 ]
Wang, Jinhui [1 ]
Yang, Jiaxin [1 ,2 ]
机构
[1] Peking Union Med Coll Hosp, Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Ovarian Neoplasms; Ovarian Diseases; PROGNOSTIC-FACTORS; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1136/ijgc-2024-005489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2-147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 50 条
  • [1] Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management
    Liu, Ying L.
    Manning-Geist, Beryl L.
    Knezevic, Andrea
    Deng, Luxue
    Bromberg, Maria
    Funt, Samuel A.
    Meisel, Jane L.
    Zivanovic, Oliver
    Roche, Kara Long
    Sonoda, Yukio
    Gardner, Ginger J.
    Grisham, Rachel N.
    O'Cearbhaill, Roisin E.
    Tew, William P.
    Abu-Rustum, Nadeem R.
    Chi, Dennis S.
    Aghajanian, Carol
    Feldman, Darren R.
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 93 - 101
  • [2] Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2015, 137 (03) : 418 - 422
  • [3] Malignant ovarian germ cell tumors - clinical characteristics and analysis of outcomes
    Miedzinska-Maciejewska, Magdalena
    Bobkiewicz, Piotr
    Gawrychowski, Krzysztof
    GINEKOLOGIA POLSKA, 2011, 82 (05) : 338 - 343
  • [4] Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors
    Wang, Jinhui
    Zhuo, Xiuping
    Yang, Jiaxin
    Cao, Dongyan
    Shen, Keng
    Huang, Huifang
    Wu, Ming
    Pan, Lingya
    Xiang, Yang
    Guo, Lina
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (04) : 1021 - 1026
  • [5] Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors
    Karalok, Alper
    Comert, Gunsu Kimyon
    Kilic, Cigdem
    Turkmen, Osman
    Kilic, Fatih
    Basaran, Derman
    Boyraz, Gokhan
    Tekin, Ozlem Moraloglu
    Turan, Taner
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2019, 48 (07) : 461 - 466
  • [6] Fertility management for malignant ovarian germ cell tumors patients
    Di Tucci, Chiara
    Casorelli, Assunta
    Morrocchi, Elisa
    Palaia, Innocenza
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 : 34 - 42
  • [7] Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes
    Tangjitgamol, Siriwan
    Hanprasertpong, Jitti
    Manusirivithaya, Sumonmal
    Wootipoom, Virach
    Thavaramara, Thaovalai
    Buhachat, Rakchai
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (02) : 182 - 189
  • [8] Prognostic Impact of Laterality in Malignant Ovarian Germ Cell Tumors
    Mahdi, Haider
    Kumar, Sanjeev
    Seward, Shelly
    Semaan, Assaad
    Batchu, Ramesh
    Lockhart, David
    Tamimi, Hisham
    Munkarah, Adnan R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) : 257 - 262
  • [9] Treatment of malignant ovarian germ cell tumors and preservation of fertility
    Zhang, R.
    Sun, Y. C.
    Zhang, G. Y.
    Wu, L. Y.
    Zuo, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (05) : 489 - 492
  • [10] Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors
    Jinhui Wang
    Xiuping Zhuo
    Jiaxin Yang
    Dongyan Cao
    Keng Shen
    Huifang Huang
    Ming Wu
    Lingya Pan
    Yang Xiang
    Lina Guo
    Archives of Gynecology and Obstetrics, 2020, 301 : 1021 - 1026